Plasma ZAG concentration was however 2.3-fold higher in CKD 5 (ESRD) patients as compared with non-CKD patients or CKD stage 1 to 4 patients (Kruskall & Wallis test, P<0.005). This evidence concerns the gene AZGP1 and chronic kidney disease.